Filing Details

Accession Number:
0001209191-23-005748
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-31 17:17:44
Reporting Period:
2023-01-27
Accepted Time:
2023-01-31 17:17:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422143 Kura Oncology Inc. KURA Pharmaceutical Preparations (2834) 611547851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1797209 Kirsten Flowers C/O Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego CA 92130
Cco & Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-27 1,906 $13.89 20,605 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.